Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors

Protein Science

Volumn 9, Issue 6, 2000, Pages 1063-1072

  Harel, Michal ^a   Kryger, Gitay ^a   Rosenberry, Terrone L ^b   Mallender, William D ^b   Lewis, Terence ^c   Fletcher, Rodney J ^c   Guss, J Mitchell ^a,d   Silman, Israel ^a   Sussman, Joel L ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MAYO CLINIC   (United States)

^c JEALOTT S HILL RESEARCH STATION   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anticholinesterase; Insect acetylcholinesterase; Insecticide; Insecticide resistance

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; INSECTICIDE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DROSOPHILA MELANOGASTER; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME INHIBITOR COMPLEX; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; INSECTICIDE RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; TORPEDO CALIFORNICA; VERTEBRATE;

DROSOPHILA MELANOGASTER; INSECTA; MELANOGASTER; TORPEDO CALIFORNICA; VERTEBRATA;

EID: 0033945085     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.6.1063     Document Type: Article

References (48)

1. Bailey S. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D50:760-763.
2. Barton GJ. 1993. ALSCRIPT, a tool to format multiple sequence alignments. Protein Eng 6:37-40.
3. Botti SA, Felder CE, Sussmun JL, Silman I. 1998. Electrotactins: A class of adhesion proteins with conserved electrostatic and structural motifs. Protein Eng 11:415-420.
4. Bourne Y, Taylor P, Bougis PE, Marchot P. 1999. Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J Biol Chem 274:2963-2970.
5. Bourne Y, Taylor P, Marchot P. 1995. Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex. Cell 83:503-512.
6. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D54:905-921.
7. Brünger AT, Adams PD, Rice LM. 1997. New applications of simulated annealing in X-ray crystallography and solution NMR. Structure 5:325-336.
8. Casida JE, Quistad GB. 1998. Golden age of insecticide research: Past, present, or future? Annu Rev Entomol 43:1-16.
9. Davis KL, Powchik P. 1995. Tacrine. Lancet 345:625-630.
10. Ellman GL, Courtney KD, Andres V Jr. Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
11. Esnouf RM. 1999. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr D55:938-940.
12. Felder CE, Botti SA, Lifson S, Silman I, Sussman JL. 1997. External and internal electrostatic potentials of cholinesterase models. J Mol Graphics Modelling 15:318-327.
13. Fournier D, Mutero A, Pralavorio M, Bride J-M. 1993. Drosophila acetylcholinesterase: Mechanisms of resistance to organophosphates. Chem Biol Interact 87:233-238.
14. Gnagey AL, Forte M, Rosenberry TL. 1987. Isolation and characterization of acetylcholinesterase from Drosophila. J Biol Chem 262:13290-13298.
15. Harel M, Quinn DM, Nair HK, Silman I, Sussman JL. 1996. The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. J Am Chem Soc 118:2340-2346.
16. Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen P, Silman I, Sussman JL. 1993. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 90:9031-9035.
17. Incardona JP, Rosenberry TL. 1996. Construction and characterization of secreted and chimeric transmembrane forms of Drosophila acetylcholinesterase: A large truncation of the C-terminal signal peptide does not eliminate glycoinositol phospholipid anchoring. Mol Biol Cell 7:595-611.
18. Jones TA, Zou J-Y, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:110-119.
19. Kleywegt GJ, Jones TA. 1994. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr D50:178-185.
20. Kraulis P. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structure. J Appl Crystallogr 24:946-950.
21. Kryger G, Giles K, Harel M, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel N, Shafferman A, et al. 1998. 3D Structure at 2.7Å resolution of native and E202Q mutant human acetylcholinesterase complexed with fasciculin-II. In: Doctor BP, Taylor P, Quinn DM, Rotundo RL, Gentry MK. eds. Structure and function of cholinesterases and related proteins. New York: Plenum. pp 323-326.
22. Kryger G, Silman I, Sussman JL. 1999. Structure of acetylcholinesterase complexed with E2020 (Aricept®): Implications for the design of new anti-Alzheimer drugs. Structure 7:297-307.
23. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
24. Laskowski RA, MacArthur MW, Moss D, Thornton JM. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
25. Martin RJ. 1997. Modes of action of anthelmintic drugs. Vet J 154:11-34.
26. Merritt EA, Bacon DJ. 1997. Raster3D - Photorealistic molecular graphics. Methods Enzymol 277:505-524.
27. Millard CB, Broomfield CA. 1995. Anticholinesterases: Medical applications of neurochemical principles. J Neurochem 64:1909-1918.
28. Moretto A, Lotti M. 1998. Poisoning by organophosphorus insecticides and sensory neuropathy. J Neural Neurosurg Psychiatry 64:463-468.
29. Mukhopadhyay AK, Karmakar P, Hati AK, Dey P. 1997. Recent epidemiological status of malaria in Calcutta Municipal Corporation area. West Bengal. Indian J Malariol 34:188-196.
30. Navaza J. 1994. AMoRe - An automated procedure for molecular replacement. Acta Crystallogr D50:157-163.
31. Nicholls A, Sharp K, Honig B. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct Funct Genet 11:281-296.
32. Nightingale SL. 1997. Donepezil approved for treatment of Alzheimer's disease. JAMA 277:10.
33. Ollis DL, Cheah E, Cygler M, Dijkstra B, Frolow F, Franken SM, Harel M, Remington SJ, Silman I, Schrag J, et al. 1992. The α/β hydrolase fold. Protein Eng 5:197-211.
34. Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. 1993. Dissection of the human acetylcholinesterase active center - Determinants of substrate specificity - Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem 268:17083-17095.
35. Otwinowski Z, Minor W. 1997, Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
36. Philippsen A. 2000. DINO: Visualizing structural biology, http://www.bioz. unibas.ch/~xray/dino.
37. Raves ML, Harel M, Pang Y-P, Silman I, Kozikowski AP, Sussman JL. 1997. 3D Structure of acetylcholinesterase complexed with the nootropic alkaloid. (-)-huperzine A. Nat Struct Biol 4:57-63.
38. Rosenberry TL. 1975. Acetylcholinesterase. Adv Enzymol 43:103-218.
39. Rosenberry TL, Scoggin DM. 1984. Structure of human erythrocyte acetylcholinesterase. J Biol Chem 259:5643-5652.
40. Sauer O, Schmidt A, Kratky C. 1997. Freeze-trapping isomorphous xenon derivatives of protein crystals. J Appl Crystallogr 30:476-486.
41. Shani A. 1998. Integrated pest management using pheromones. Chemtech 28:30-35.
42. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. 1991. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science 253:872-879.
43. Taylor P. 1996. Anticholinesterase agents. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill. pp 161-176.
44. Veil S. 1992. Our planet, our health. New York: WHO Commission on Health and Environment, World Health Organization.
45. Vellom DC, Radic Z, Li Y, Pickering NA, Camp S, Taylor P. 1993. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry 32:12-17.
46. Vriend G. 1990. WHAT IF: A molecular modelling and drug design program. J Mol Graphics Modelling 8:52-56.
47. Weik M, Ravelli RBG, Kryger G, McSweeney S, Raves M, Harel M, Gros P, Silman I, Kroon J, Sussman JL. 2000. Specific chemical and structural damage to proteins produced by synchrotron radiation. Proc Natl Acad Sci USA 97:623-628.
48. Yao H, Chuanling Q, Williamson MS, Devonshire AL. 1997. Characterization of the acetylcholinesterase gene from insecticide-resistant houseflies (Musca domestica). Chin J Biotechnol 13:177-183.